<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38482">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873222</url>
  </required_header>
  <id_info>
    <org_study_id>TRICVD1311</org_study_id>
    <secondary_id>UMIN000010581</secondary_id>
    <nct_id>NCT01873222</nct_id>
  </id_info>
  <brief_title>OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging</brief_title>
  <official_title>OPtical Frequency Domain Imaging vs. INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Informatics Center, Kobe, Hyogo, Japan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wakayama Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Translational Research Informatics Center, Kobe, Hyogo, Japan</source>
  <oversight_info>
    <authority>Japan: Ethics Committee of Wakayama Medical University</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to
      evaluate how Optical frequency domain imaging (OFDI) or Intravascular Ultrasound (IVUS)
      imaging technology influence to the Percutaneous Coronary Intervention (PCI) strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optical frequency domain imaging (OFDI) is a novel, high resolution intravascular imaging
      modality. Intravascular ultrasound (IVUS) is a widely used conventional imaging modality for
      achieving optimal stent deployment.

      This study is the sub-study of OPINION Trial. (UMIN000010580) The aim of this study is to
      evaluate how OFDI or IVUS imaging technology influence to the Percutaneous Coronary
      Intervention (PCI) strategy.

      We will enroll the first 100 patients who have enrolled in the main-study of OPINION
      trial.(UMIN000010580). We will assess lesions by the other device in addition to the
      assigned device in the main study at the time of post-PCI.

      We will then assess lesions by OFDI at a 8-month follo-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Frequency of malapposed struts</measure>
    <time_frame>post-PCI</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess &quot;Frequency of malapposed struts&quot; by OFDI at post-PCI.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum stent area</measure>
    <time_frame>post-PCI</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess &quot;Minimum stent area&quot; by IVUS at post-PCI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dissection</measure>
    <time_frame>post-PCI</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess &quot;Dissection&quot; by OFDI at post-PCI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of uncovered struts</measure>
    <time_frame>8 months after PCI</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess &quot;Frequency of uncovered struts&quot; by OFDI at 8 months after PCI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum lumen area</measure>
    <time_frame>8-month follow-up after PCI</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess &quot;Minimum lumen area by OFDI at 8 months after PCI.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>OFDI-guided PCI &amp; IVUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment by IVUS at post-PCI
Assessment by OFDI at a 8-month follow-up</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVUS-guided PCI &amp; OFDI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assessment by OFDI at post-PCI
Assessment by OFDI at a 8-month follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OFDI-guided PCI &amp; IVUS</intervention_name>
    <description>Assessment by IVUS at post-PCI
Assessment by OFDI at a 8-month follow-up</description>
    <arm_group_label>OFDI-guided PCI &amp; IVUS</arm_group_label>
    <other_name>OFDI</other_name>
    <other_name>LUNAWAVE</other_name>
    <other_name>Biolimus A9-eluting stent (Nobori stent)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IVUS-guided PCI &amp; OFDI</intervention_name>
    <description>Assessment by OFDI at post-PCI
Assessment by OFDI at a 8-month follow-up</description>
    <arm_group_label>IVUS-guided PCI &amp; OFDI</arm_group_label>
    <other_name>VISIWAVE</other_name>
    <other_name>ViewIT</other_name>
    <other_name>Biolimus A9-eluting stent (Nobori stent)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients participating in the OPINION Trial

          -  Patients who has provided written informed consent

        Exclusion Criteria:

          -  Ineligible patients according to the investigator's judgment

          -  Inability or unwillingness to perform required follow up procedures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takashi Akasaka, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wakayama Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Takashi Kubo, MD, PhD</last_name>
    <phone>+81-73-441-0621</phone>
    <email>OPINION@tri-kobe.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wakayama Medical University</name>
      <address>
        <city>Wakayama</city>
        <state>Wakayama Prefecture</state>
        <zip>641-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takashi Akasaka, MD, PhD</last_name>
      <phone>+81-73-441-0621</phone>
      <email>OPINION@tri-kobe.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>May 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Optical Frequency Domain Imaging</keyword>
  <keyword>Intravascular Ultrasound</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
